Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorJena University Hospital
About this trial
Intensive Lipid-Lowering Therapy guided by a cloud-based Software System (CLIMEDO GmbH) improves (European Society of Cardiolofgy/European Atherosclerosis Society) ESC/EAS-guideline recommended LDL-cholesterol target attainment and adherence in patients with ST-Elevation Myocardial (STEMI) and Non-ST-Elevation Myocardial Infarctions (NSTEMI).
Eligibility criteria
Qualifiers
patients with ST- and Non-ST-elevation myocardial infarctions
Disqualifiers
patient without informed concent
patients in cardiogenic shock
patients with contraindication to lipid-lowering therapy
patients on lipid-lowering medications on admission
Trial design
Treatments tested in this trial
- statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
Treatment groups
300 Participants
are divided into 2 treatment groupsLocations
10University Hospital Jena07747, JenaThuringia, Germany
Universitätsmedizin Berlin Berlin Germany
Universitätsklinikum Dresden Dresden Germany
Universitätsklinikum Essen Essen Germany
Sponsors and collaborators
Jena University Hospital
Lead sponsor
Source ClinicalTrials.gov